healthcare working in laboratory

Healthtech Fund

A diversified portfolio of healthtech & life sciences investments.

FUND THESIS:

The next generation of iconic healthcare companies won’t simply disrupt — they’ll re-architect. This fund invests in bold founders building at the intersection of infrastructure, care delivery, and frontier science. We back entrepreneurs transforming friction into flywheels — turning the complexity of healthcare into an enduring competitive advantage. These are the builders aligning access, quality, and cost in ways the system never has — and unlocking venture-scale returns in the process.

WHY NOW:

Healthcare is at a breaking point — and a tipping point. A $4.9 trillion system under pressure from rising costs, outdated infrastructure, and shifting policy is colliding with transformative forces: AI, computational biology, and new models of care. The result? A once-in-a-generation opportunity to rebuild the rails of healthcare. As top firms double down and thematic funds surge, we’re backing the visionary founders who aren’t skirting the system — they’re rebuilding it from within.


Access Our Award-Winning Content

  • Home

    Free access to content on innovation, tech and VC
  • Home

    Access award-winning educational webinar series
  • Home

    Venture trends from our team of 40 investing professionals
  • Home

    Sign up to access for free

Invest in the Fund

Let our expert team handle it for you.

Our award-winning venture investing professionals will build a diversified portfolio of venture-backed companies for you.

Questions?
📱 Text (650) 410-8600 for Info
📞 Short Intro Call

Invest Deal-by-Deal

You select individual companies to invest in.

Join our Healthtech Syndicate to review deals one at a time. We’ll share diligence materials for informed decision making.

Questions?
📱 Text (650) 410-8600 for Info
📞 Short Intro Call


Investment Areas of Interest

Operational Infrastructure →
Digitizing the Messy Middle. Software solutions modernizing the behind-the-scenes machinery of healthcare — from revenue cycle to credentialing, claims, and prior authorization. These startups reduce friction in workflows and automate what legacy systems can’t.
Portfolio companies: Anomaly, Capital Rx, Parachute Health

Data & Compliance Platforms →
Powering the Rails of Modern Healthcare. Tools that ensure interoperability, security, and compliance across the healthcare stack — from FHIR and HIPAA to FDA-aligned data systems. These companies embed deeply into payers, providers, and systems of record.
Portfolio companies: Clarium Health, Canid, Centaur Labs

Full-Stack Care →
Reimagining How and Where Care Happens. Tech-enabled platforms delivering high-quality, longitudinal care across physical, virtual, and hybrid models. Designed for value-based care and built to scale across Medicare, Medicaid, and employer-sponsored plans.
Portfolio companies: Pearl Health, Centivo, Sondermind

Frontier Science →
The Future of Healing. AI-powered drug discovery, omics-based diagnostics, and novel therapeutics redefining what it means to age, heal, and thrive. These category-defining biotech companies use data and computation to reshape the clinical curve.
Portfolio companies: Precision Neuroscience, Cytovale


Awards & Recognition


  • Home

    Invest in ventures innovating in healthtech and life sciences
  • Home

    ~20-30 venture investments made over ~12-18 months— diversified by subsector, geography, region
  • Home

    Reserves ~20% to pursue follow-on opportunities in the most promising portfolio investments
  • Home

    Investments sourced by a team of dedicated investing professionals, our network of handpicked Scouts, AV’s 750k+ supporters, and other AV funds
  • Home

    Part of Alumni Ventures, America's Largest Venture Firm for Individuals and a "Top 20 Venture Firm" (CB Insights '24)

See video policy below.


AV Co-Invests with Experienced Venture Firms

250+ investments with leading VCs and many with other top-quartile firms.

These leading venture firms have backed some of the most successful companies in the world.
Co-investors are shown for illustrative purposes only, do not represent all co-investors with which Alumni Ventures as invested, and are not necessarily indicative of future co-investors. The identity of a co-investor does not guarantee investment quality or performance.


20 ventures from the Alumni Ventures portfolio that we’re excited about for 2025


Invest in Startups Like the Healthtech Apex 20

Accredited investors can invest in startups like the Apex 20 with Alumni Ventures. Talk with a Senior Partner about our portfolio of over 1400 companies to learn more about becoming an investor.

Or simply text us with your question for fast response
650-410-8600


Fundraise Timing & Loyalty Rewards

The fundraise deadlines of current and upcoming fund vintages are published below to help our investors with their personal venture allocation planning strategies. Read more about our Loyalty Rewards, Performance, and Fees.


About Alumni Ventures

We are a venture capital firm that provides accredited investors & institutions with access to professionally-managed, diversified venture portfolios. Our network is among the largest and most well-connected in the industry.

  • Home

    #1 most active venture firm in the U.S., #3 in the world (PitchBook '22 & '23)
  • Home

    $1.3B+ capital raised since founding in 2014
  • Home

    Diversified historical portfolio of 1,400+ venture-backed companies, adding ~250 / year
  • Home

    10,500 individual accredited investors already trust us with their venture investing
  • Home

    Top 20 Venture Firm (CB Insights '24)
  • Home

    Top-quartile performance*
  • Home

    Network of 850k+ investors, entrepreneurs, & community members
  • Home

    5 national offices & ~40 full-time venture investors

2022 Pitchbook Global League Tables, 2023 Pitchbook Global League Tables  

The Top 20 venture investors in North America

*Top-Quartile for AV Fund vintages 2016-2020 as of September 30, 2024. Top Quartile ranking against Cambridge Associates’ peer group for venture capital, according to the Distributions to Paid-in Capital (DPI) metric. Top-Quartile for 2016 vintage was .77 for Cambridge Associates peer group and .72 for Alumni Ventures funds. Past performance does not guarantee future results.


HealthTech Fund News

Content at the intersection of entrepreneurship, venture capital, and specific industry sectors.



Healthtech Fund Portfolio

We invest alongside other established venture firms in a broad range of ventures to help build you a diversified venture portfolio.


Access Fund Materials

  • Home
    Fund information
  • Home
    Performance data
  • Home
    Speak with our team

Review on your own, chat online, or speak with our team.